Starboard seeks probe after former Pfizer execs pull support for its campaign

(Reuters) - Starboard Value has asked Pfizer (NYSE:PFE ) to set up a special committee to investigate allegations that two of its former senior executives were forced to publicly declare support for CEO Albert Bourla, the hedge fund said on Thursday.

Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio, who were reportedly helping the activist investor in its plan to push the company for a turnaround, said late on Wednesday that they would not support Starboard.

The hedge fund said it was made aware that the two executives had been contacted by "people within Pfizer", who had threatened to commence litigation against them unless they released a statement supporting Bourla.



Pfizer did not immediately respond to a request for comment.

Starboard said it was scheduled to meet Bourla and possibly other members of the board on Oct. 16 to "discuss the best path forward for Pfizer."

Source: Investing.com

Последние публикации
MedTech sector outlook for 2025: RBC
21.12.2024 - 12:00
Investing.com’s stocks of the week
21.12.2024 - 12:00
Here is the 2025 global real estate outlook according to RBC
21.12.2024 - 11:00
14 lessons from 2025 to remember in 2025: BofA
21.12.2024 - 11:00
GLP-1: Barclays on why 2025 could be an inflection point
21.12.2024 - 10:00
U.S. housing market to improve in 2025, but challenges persist
21.12.2024 - 10:00
Honda and Nissan consider mutual production of vehicles, Kyodo reports
21.12.2024 - 09:00
Google offers to loosen search deals in US antitrust case remedy
21.12.2024 - 06:00
Google says it could loosen search deals in US antitrust case
21.12.2024 - 05:00
US judge finds Israel's NSO Group liable for hacking in WhatsApp lawsuit
21.12.2024 - 03:00
Qualcomm secures key win in chips trial against Arm
21.12.2024 - 02:00
US, Israeli officials deny approving sale of Israeli spyware firm to US investors
21.12.2024 - 00:00
Arm lawsuit ends in mistrial with Qualcomm securing key win
21.12.2024 - 00:00
US finalizes up to $6.75 billion in chips awards for Samsung, Texas Instruments, Amkor
21.12.2024 - 00:00
Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea
21.12.2024 - 00:00

© Analytic DC. All Rights Reserved.

new
Анализ рынка Как повлият завтра отчет NFP на курс доллара США?